After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Medical Devices industry segment. The current market capitalization of Dexcom Inc is $35.46B. A total of 4.02 million shares were traded on the day, compared to an average of 3.50M shares.
In the most recent transaction, Sylvain Jereme M sold 2,090 shares of DXCM for 86.91 per share on Jan 29 ’25. After the transaction, the EVP, Chief Financal Officer now owns 83,526 company shares. In a previous transaction on Jan 29 ’25, Dolan Matthew Vincent sold 1,183 shares at 86.91 per share. DXCM shares that EVP, Strategy & Corporate Dev owns now total 42,044.
Among the insiders who sold shares, Stern Sadie disposed of 2,093 shares on Jan 29 ’25 at a per-share price of $86.91. This resulted in the EVP, Chief HR Officer holding 74,261 shares of DXCM after the transaction. In another insider transaction, Leach Jacob Steven sold 2,634 shares at $86.91 per share on Jan 29 ’25. Company shares held by the EVP, Chief Operating Officer now total 268,644.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, DXCM has a high of $142.00 and a low of $62.34.
As of this writing, DXCM has an earnings estimate of $0.33 per share for the current quarter. EPS was calculated based on a consensus of 20.0 estimates, with a high estimate of $0.43 per share and a lower estimate of $0.28.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. DXCM’s latest balance sheet shows that the firm has $2.73B in Cash & Short Term Investments as of fiscal 2021. There were $2.16B in debt and $720.80M in liabilities at the time. Its Book Value Per Share was $5.38, while its Total Shareholder’s Equity was $2.04B.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DXCM is Buy with a score of 4.68.
